Nav: Home

Switching from smoking to glo significantly reduces exposure to toxicants

February 24, 2018

A clinical study conducted by scientists at British American Tobacco have revealed that when smokers switch completely from cigarettes to glo, their exposure to certain cigarette smoke toxicants is significantly reduced, in some cases to levels comparable to those seen in smokers who quit smoking completely.

These results add to evidence suggesting that glo may have the potential to be substantially reduced risk compared to smoking conventional cigarettes.

glo is a tobacco heating product (THP) designed to heat rather than burn tobacco. This means it does not produce smoke and certain toxicants associated with tobacco combustion are substantially reduced. Previous studies revealed toxicant levels in the heated tobacco vapour from glo to be around 90-95% less than in cigarette smoke.

'Products like glo are very new and consumers and regulators alike understandably want as much information as possible about them. Understanding how vapour from glo compares to cigarette smoke is, therefore, a core component of our scientific research,' said Dr James Murphy, Head of Reduced Risk Substantiation at British American Tobacco. 'Clinical studies, which are studies involving real people, are an extremely important component of that,' he said.

Because glo vapour has lower levels of toxicants than cigarette smoke, it should in principle expose consumers to much less toxicants. The results of this study indicate that this is indeed the case. The results are presented today at the annual conference of the Society for Nicotine and Tobacco Research in Baltimore, Maryland, USA.

Clinical Study

This clinical study was conducted in Japan because THPs like glo are popular there. One hundred and eighty people participated in the study, which was conducted over a period of eight days in a clinic. They were all smokers for at least three years prior to enrolment.

For the first two days, study participants continued to smoke as normal and their urine was collected to measure levels of chemicals. Blood and breath were also collected for analysis.

For the next five days, participants were randomly allocated to either continue smoking, switch to using a THP or quit smoking. Urine, blood and breath samples were again collected for analysis.

Exposure to certain smoke toxicants was determined by measuring the levels of certain chemicals in the urine. These could be the toxicants themselves or their metabolites - which is what the body breaks it down into - called biomarkers of exposure. Toxicants measured included those identified by the World Health Organisation as being of concern in cigarette smoke.

The results show that the concentration of certain chemicals in the urine was reduced in smokers who switched to glo. In some cases, these reductions were the same as those in smokers who quit (Figure 1). This suggests that smokers who switched to glo were exposed to less toxicants - in some cases, their exposure was the same as smokers who quit altogether.

'These results are very encouraging,' explains Murphy. 'The next step will be to determine whether this reduction in exposure translates to a reduced biological effect, and in turn a reduction in adverse health effects for those smokers who switch completely to glo,' he said.

Future clinical studies will test for markers of biological effect, like cholesterol levels or heart rate (i.e. measurements that give an indication of general health). A reduction in biomarkers of biological effect could suggest that a reduction in exposure is having a positive impact on reducing the adverse health risks of smokers who switch completely.

'The results of one test are important,' said Murphy, 'but it is the combination of the results of many different tests that start to give us a real feel for the bigger picture and the potential for glo to be reduced risk compared to a conventional cigarette.'
-end-
British American Tobacco's Commitment to NGPs

British American Tobacco has invested more than US$2.5 billion over the last six years in developing and commercialising a world-leading portfolio of products in the Next Generation Products (NGPs) category. British American Tobacco currently has NGPs in 17 markets with plans to be double the amount of markets we're in by the end of 2018. BAT has a bold ambition to realise revenue of more than £5bn from NGPs by 2022.

R&D at British American Tobacco

Related Smokers Articles:

Most remaining smokers in US have low socioeconomic status
After decades of declining US smoking rates overall, most remaining smokers have low income, no college education, no health insurance or a disability.
Radiotherapy risks are much higher for smokers
Smokers treated for breast cancer have much higher risks than non-smokers of developing lung cancer or heart attack as a result of radiotherapy -- according to a new study funded by Cancer Research UK and published today in the Journal of Clinical Oncology.
E-cigarettes popular among smokers with existing illnesses
In the US more than 16 million people with smoking-related illnesses continue to use cigarettes.
Smokers' memories could help them quit
Rather than inciting fear, anti-smoking campaigns should tap into smokers' memories and tug at their heartstrings, finds a new study by Michigan State University researchers.
Among colon cancer patients, smokers have worse outcomes than non-smokers
In an analysis of more than 18,000 patients treated for colon cancer, current smokers were 14 percent more likely to die from their colon cancer within five years than patients who had never smoked.
Diabetes proves deadly for smokers
While it is well known that smoking causes lung cancer, heavy smokers with diabetes are also at increased risk of death from causes other than lung cancer, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).
New treatment for depressed smokers trying to quit
Researchers pinpoint why depressed smokers have a harder time resisting relapses.
Smokers with depression try to quit more often but find it harder
People diagnosed with depression are about twice as likely to smoke as the general population.
Differences found between smokers and non-smokers who develop lung cancer
Tobacco smoke is known to be the main risk factor for non-small cell lung cancer (NSCLC), although non-smokers can get it too.
Heavy smokers and smokers who are obese gain more weight after quitting
For smokers, the number of cigarettes smoked per day and current body mass index are predictive of changes in weight after quitting smoking, according to researchers at Penn State College of Medicine.

Related Smokers Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".